New Approach to Immunotherapy Leads to Complete Response in Breast Cancer Patient Unresponsive to Other Treatments
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments.